Board No.
P01 Neurovespina: New peptide for the treatment of neurological diseases
Lilian Carneiro dos Anjos, Brazil
P02 Tracking transplanted adipose-derived stem cells in central nervous system with GFP-Luc gene reporter
Mario Faustino Muñoz, Spain
P03 Beneficial effect of agomelatine on diabetes-induced depression and cognitive deficites in rats
Umut İrfan Üçel, Turkey
P04 A novel role of microglial nadph oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis
Lulu Jiang, China
P05 Retina examination in neurodegenerative diseases
Umur A. Kayabasi, Turkey
P06 3’,4’,7-trihydroxyflavone prevents apoptotic cell death in neuronal cells from hydrogen peroxide-induced oxidative stress
Seung-Hwan Kwon, Korea
P07 Assessment of the neurotherapeutic activity of the recombinant heat shock protein Hsp70 in the rat model of Parkinson’s disease
Daria Plaksina, Russian Federation
P08 Role of the combination therapy of pioglitazone and simvastatin in lipopolysaccharide induced Alzheimer’s disease model in mice
Nesrine Salah El Dine El Sayed, Egypt
P09 Biological and chemical properties of fragment peptides derived from neurotoxic proteins
Toshifumi Akizawa, Japan
P10 Reversibility of murine motor deficits following hemi-craniectomy and cranioplasty
Brian Thomas Andrews, USA
P11 Chronic meningoencephalitis worse after rituximab
Sara Bedmar, Spain
P12 Gabapentin as the first line treatment in neuropathic pain in dogs: Indirect measurements of the pain degree and its evolution over time
Alejandro Benzal, Spain
P13 Chronic stress is a risk factor contributing to amplify and accelerate Alzheimer’s disease features in the hippocampus
Alejandro Carrillo Jimenez, Spain
P14 Intranasal ex-4 improved learning and memory after chronic TBI
Neelima B. Chauhan, USA
P15 Determination of carcinogenic stem cell lineage markers related with tumour topography and survival
Elda Chavez Cortez, Mexico
P16 The potassium eliminating therapy for the refractory status epilepticus to prevent the cardiotoxicity
Yun-Ju Choi, Korea
P17 Antioxidant treatment protects brain against ischemia-reperfusion injury through insulin receptor activation
Kangho Choi, Korea
P18 Design and production of a IgY immunotoxins to eliminate CD133+ glioma cells
Georgina Cortéz Chávez, Mexico
P19 From neurodegeneration to neurorehabilitation: The quadrato motor training model
Tal Dotan Ben-Soussan, Italy
P20 Pharmacotherapy for intellectual disability and Alzheimer’s disease in down syndrome: The challenges and the imperatives of mouse models and preclinical evaluations at the molecular level
Katheleen Gardiner, USA
P21 Functional dyspepsia in patients with Parkinson’s disease: What to do?
Costin Georgescu, Romania
P22 Imaging of cerebral malaria
Jacob Golenser, Israel
P23 Hydrocephalus reduces the cell proliferation and increases fractone complexity in the adult subventricular-ventricular zone
Oscar Gonzalez-Perez, Mexico
P24 The effects of a six-week motorized aquatic treadmill exercise program on cardiorespiratory fitness and walking endurance in subacute stroke patients
Sang Hee Im, Korea
P25 Topiramate: Preventional treatment of migrane
Adi Jakupi, Macedonia
P26 Early ambulation in patients with aneurysmal subarachnoid hemorrhage is safe and feasible, and did not result in increased cerebral vasospasm
Youngjin Jung, Korea
P27 Small volume plasma exchange in the treatment of Guillain-Barré Syndrome
Meena A. Kannan, India
P28 Longitudinal model of tau pathology allows analysis of different therapeutic options and choice of optimal biomarker
Tatiana Karelina, Russian Federation
P29 A case of diffusion and ADC map alterations associated with complex partial status
Youngjin Kim, Korea
P30 The clinical importance of f-waves as a prognostic factor in children with Guillain-Barré Syndrome
Saeyoon Kim, Korea
P31 Treatment of acute carbon monoxide poisoning with induced hypothermia
Jin Kim, Korea
P32 Measures of speech deviations associated with neurological diseases: Implication for assessment and treatment
Yunjung Kim, USA
P33 Cervical spinal dural arteriovenous fistula with extradural hematoma in child: A case report
Jangjoon Lee, Korea
P34 Involvement of the Nrf2/HO-1 signaling pathway in sulfuretin-induced protection against amyloid beta25-35 neurotoxicity
Shi-Xun Ma, Korea
P35 The role of phosphorus dendrimers in αlpha-synuclein fibrillation
Katarzyna Milowska, Poland
P36 Blood pressure variability predicts both early neurological deterioration and functional outcome in ischemic stroke
Mi Sun Oh, Korea
P37 Combination of therapeutic hypothermia and insulin-like growth factor-I in ischemic stroke rats: Effect on biomarker concentration and infarct size
Pieter Olivier, Belgium
P38 The correlation of cognitive decline and inflammatory response biomarkers level after artery bypass grafting operation
Dmitriy A. Ovchinnikov, Russian Federation
P39 Combination of therapeutic hypothermia and insulin-like growth factor-1 in ischemic stroke rats: Effect on infarct size and neurological outcome
Arnaud Roger Gabrielle Gilberte Potvin, Belgium
P40 Inhibition of proteasome induces death of neural cells via different cell death mechanisms
Peter Racay, Slovakia
P41 Effect of l-kynurenine, 3-hydroxyanthranilic acid and 3-hydroxykynurenine on cupper toxicity in primary cultured astrocytes
Daniela Ramírez Ortega, Mexico
P42 Gross motor function classification system-family report questionnaire (GMFCS-FR): Reliability between special education teachers and caregivers
Sirinan Ramrit, Thailand
P43 Isolated oculomotor nerve palsy associated with meningitis
Jong-Geun Seo, Korea
P44 The protective effect of turmeric against neuroaflatoxicosis
Ahmed Abd-Elmageid Soffar, Egypt
P45 Pine needle extract enhances hippocampal memory activity in scopolamine-induced amnesia mouse model
Chang Gue Son, Korea
P46 Challenges in implementing the ethical and legal provisions for testing advanced technology apps with seniors diagnosed with neurocognitive disorders
Alexandru Sterea, Romania
P47 Recruitment of calbindin into nigral dopaminergic neurons prevents from MPTP-induced parkinsonism
Masahiko Takada, Japan
P48 Influence of the LILRA3 deletion on Multiple Sclerosis risk: A meta-analysis
Elena Urcelay, Spain
Posters P01-P08 will also be presented in the Flash Oral Session on Saturday, September 5 from 17:45-18:30.